4,5-O-DICAFFEOYLQUINIC-ACID
Compound with spectra: 2 NMR
| SpectraBase Compound ID | Hm9PXgD6a47 |
|---|---|
| InChI | InChI=1S/C25H24O12/c26-15-5-1-13(9-17(15)28)3-7-21(31)36-20-12-25(35,24(33)34)11-19(30)23(20)37-22(32)8-4-14-2-6-16(27)18(29)10-14/h1-10,19-20,23,26-30,35H,11-12H2,(H,33,34)/b7-3+,8-4+/t19-,20-,23-,25+/m0/s1 |
| InChIKey | UFCLZKMFXSILNL-ZSGFIFMUSA-N |
| Mol Weight | 516.46 g/mol |
| Molecular Formula | C25H24O12 |
| Exact Mass | 516.126776 g/mol |
| Enantiomer InChIKey | UFCLZKMFXSILNL-PSEXTPKNSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
- 4,5-DI-O-CAFFEOYLQUINIC-ACID
(1S,3R,4S,5R)-3,4-BIS-([(E)-3-(3,4-DIHYDROXYPHENYL)-PROP-2-ENOYL]-OXY)-1,5-DIHYDROXYCYCLOHEXANECARBOXYLIC-ACID
4,5-O-DICAFFEOYLQUINIC-ACID
4,5-DI-O-CAFFEOYLQUINIC-ACID
3,4-DI-O-CAFFEOYL-QUINIC-ACID
(1S,3R,4R,5R)-3,4-BIS-([(E)-3-(3,4-DIHYDROXYPHENYL)-PROP-2-ENOYL]-OXY)-1,5-DIHYDROXYCYCLOHEXANECARBOXYLIC-ACID
IRBIC-ACID;3,5-DICAFFEOYL-4-O-MALONYLQUINIC-ACID
2-Nitrochlorogenic acid
1,3,5-TRI-O-CAFFEOYL-QUINIC-ACID
1-ISOBUTYRYL-3,5-DICAFFEOYLQUINIC-ACID
3,4,5-TRI-O-GALLOYLQUINIC-ACID
3-O-[3,4-(DIMETHOXY)-CINNAMOYL]-1,5-GAMMA-QUINIDE
BREVIPOLIDE_E
(1S,2R,4R,6R,8S)-4-(methoxycarbonyl)-8-phenyl-7,9-dioxabicyclo[4.3.0]nonane-2,4-diol
| Title | Journal or Book | Year |
|---|---|---|
| Irbic acid, a dicaffeoylquinic acid derivative from Centella asiatica cell cultures | Fitoterapia | 2011 |
| Immunomodulatory Principles of Dichrocephala bicolor | Journal of Natural Products | 1999 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.